FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143193348> ?p ?o ?g. }

• W2143193348 endingPage "212" @default.
• W2143193348 startingPage "206" @default.
• W2143193348 abstract "Background. Poisoning due to deliberate self-harm with the seeds of yellow oleander (Thevetia peruviana) results in significant morbidity and mortality each year in South Asia. Yellow oleander seeds contain highly toxic cardiac glycosides including thevetins A and B and neriifolin. A wide variety of bradyarrhythmias and tachyarrhythmias occur following ingestion. Important epidemiological and clinical differences exist between poisoning due to yellow oleander and digoxin; yellow oleander poisoning is commonly seen in younger patients without preexisting illness or comorbidity. Assessment and initial management. Initial assessment and management is similar to other poisonings. No definite criteria are available for risk stratification. Continuous ECG monitoring for at least 24 h is necessary to detect arrhythmias; longer monitoring is appropriate in patients with severe poisoning. Supportive care. Correction of dehydration with normal saline is necessary, and antiemetics are used to control severe vomiting. Electrolytes. Hypokalemia worsens toxicity due to digitalis glycosides, and hyperkalemia is life-threatening. Both must be corrected. Hyperkalemia is due to extracellular shift of potassium rather than an increase in total body potassium and is best treated with insulin-dextrose infusion. Intravenous calcium increases the risk of cardiac arrhythmias and is not recommended in treating hyperkalemia. Oral or rectal administration of sodium polystyrene sulfonate resin may result in hypokalemia when used together with digoxin-specific antibody fragments. Unlike digoxin toxicity, serum magnesium concentrations are less likely to be affected in yellow oleander poisoning. The effect of magnesium concentrations on toxicity and outcome is not known. Hypomagnesaemia should be corrected as it can worsen cardiac glycoside toxicity. Gastric decontamination. The place of emesis induction and gastric lavage has not been investigated, although they are used in practice. Gastric decontamination by the use of single dose and multiple doses of activated charcoal has been evaluated in two randomized controlled trials, with contradictory results. Methodological differences (severity of poisoning in recruited patients, duration of treatment, compliance) between the two trials, together with differences in mortality rates in control groups, have led to much controversy. No firm recommendation for or against the use of multiple doses of activated charcoal can be made at present, and further studies are needed. Single-dose activated charcoal is probably beneficial. Activated charcoal is clearly safe. Arrhythmia management. Bradyarrhythmias are commonly managed with atropine, isoprenaline, and temporary cardiac pacing in severe cases, although without trial evidence of survival benefit, or adequate evaluation of possible risks. Accelerating the heart rate with atropine or β-adrenergic agents theoretically increases the risk of tachyarrhythmias, and it has been claimed that atropine increases tachyarrhythmic deaths. Further studies are required. Tachyarrhythmias have a poor prognosis and are more difficult to treat. Lidocaine is the preferred antiarrhythmic; the role of intravenous magnesium is uncertain. Digoxin-specific antibody fragments. Digoxin-specific antibody fragments are effective in reverting life-threatening cardiac arrhythmias; prospective observational studies show a beneficial effect on mortality. High cost and lack of availability limit the widespread use of digoxin-specific antibody fragments in developing countries. Conclusions. Digoxin-specific antibody fragments remain the only proven therapy for yellow oleander poisoning. Further studies are needed to determine the place of activated charcoal, the benefits or risks of atropine and isoprenaline, the place and choice of antiarrhythmics, and the effect of intravenous magnesium in yellow oleander poisoning." @default.
• W2143193348 created "2016-06-24" @default.
• W2143193348 creator A5019645192 @default.
• W2143193348 date "2009-03-01" @default.
• W2143193348 modified "2023-10-15" @default.
• W2143193348 title "Management of yellow oleander poisoning" @default.
• W2143193348 cites W1967111809 @default.
• W2143193348 cites W1967584454 @default.
• W2143193348 cites W1969383508 @default.
• W2143193348 cites W1970284387 @default.
• W2143193348 cites W1972063745 @default.
• W2143193348 cites W1978449283 @default.
• W2143193348 cites W1982913074 @default.
• W2143193348 cites W1982975090 @default.
• W2143193348 cites W1986154573 @default.
• W2143193348 cites W1994938734 @default.
• W2143193348 cites W1996907597 @default.
• W2143193348 cites W1999833172 @default.
• W2143193348 cites W2000066182 @default.
• W2143193348 cites W2015462326 @default.
• W2143193348 cites W2020017961 @default.
• W2143193348 cites W2040715884 @default.
• W2143193348 cites W2041801434 @default.
• W2143193348 cites W2047199285 @default.
• W2143193348 cites W2055582779 @default.
• W2143193348 cites W2062330131 @default.
• W2143193348 cites W2073321635 @default.
• W2143193348 cites W2081636403 @default.
• W2143193348 cites W2087673177 @default.
• W2143193348 cites W2088120257 @default.
• W2143193348 cites W2088362721 @default.
• W2143193348 cites W2088386088 @default.
• W2143193348 cites W2092694799 @default.
• W2143193348 cites W2095644921 @default.
• W2143193348 cites W2102752459 @default.
• W2143193348 cites W2103601476 @default.
• W2143193348 cites W2106657249 @default.
• W2143193348 cites W2112051701 @default.
• W2143193348 cites W2119768791 @default.
• W2143193348 cites W2121038608 @default.
• W2143193348 cites W2121792389 @default.
• W2143193348 cites W2123443387 @default.
• W2143193348 cites W2133855882 @default.
• W2143193348 cites W2140759277 @default.
• W2143193348 cites W2145589426 @default.
• W2143193348 cites W2169456510 @default.
• W2143193348 cites W2172519975 @default.
• W2143193348 cites W2315659479 @default.
• W2143193348 cites W2887972550 @default.
• W2143193348 cites W4247115498 @default.
• W2143193348 cites W4255009844 @default.
• W2143193348 cites W45784874 @default.
• W2143193348 doi "https://doi.org/10.1080/15563650902824001" @default.
• W2143193348 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19306191" @default.
• W2143193348 hasPublicationYear "2009" @default.
• W2143193348 type Work @default.
• W2143193348 sameAs 2143193348 @default.
• W2143193348 citedByCount "60" @default.
• W2143193348 countsByYear W21431933482012 @default.
• W2143193348 countsByYear W21431933482013 @default.
• W2143193348 countsByYear W21431933482014 @default.
• W2143193348 countsByYear W21431933482015 @default.
• W2143193348 countsByYear W21431933482016 @default.
• W2143193348 countsByYear W21431933482017 @default.
• W2143193348 countsByYear W21431933482018 @default.
• W2143193348 countsByYear W21431933482019 @default.
• W2143193348 countsByYear W21431933482020 @default.
• W2143193348 countsByYear W21431933482021 @default.
• W2143193348 countsByYear W21431933482022 @default.
• W2143193348 countsByYear W21431933482023 @default.
• W2143193348 crossrefType "journal-article" @default.
• W2143193348 hasAuthorship W2143193348A5019645192 @default.
• W2143193348 hasConcept C126322002 @default.
• W2143193348 hasConcept C193230392 @default.
• W2143193348 hasConcept C2777707475 @default.
• W2143193348 hasConcept C2778198053 @default.
• W2143193348 hasConcept C2778242168 @default.
• W2143193348 hasConcept C2779365888 @default.
• W2143193348 hasConcept C2780243291 @default.
• W2143193348 hasConcept C29730261 @default.
• W2143193348 hasConcept C42219234 @default.
• W2143193348 hasConcept C71924100 @default.
• W2143193348 hasConceptScore W2143193348C126322002 @default.
• W2143193348 hasConceptScore W2143193348C193230392 @default.
• W2143193348 hasConceptScore W2143193348C2777707475 @default.
• W2143193348 hasConceptScore W2143193348C2778198053 @default.
• W2143193348 hasConceptScore W2143193348C2778242168 @default.
• W2143193348 hasConceptScore W2143193348C2779365888 @default.
• W2143193348 hasConceptScore W2143193348C2780243291 @default.
• W2143193348 hasConceptScore W2143193348C29730261 @default.
• W2143193348 hasConceptScore W2143193348C42219234 @default.
• W2143193348 hasConceptScore W2143193348C71924100 @default.
• W2143193348 hasIssue "3" @default.
• W2143193348 hasLocation W21431933481 @default.
• W2143193348 hasLocation W21431933482 @default.
• W2143193348 hasOpenAccess W2143193348 @default.
• W2143193348 hasPrimaryLocation W21431933481 @default.
• W2143193348 hasRelatedWork W1983053368 @default.

• next